Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ottinger

Showing results (511-520 of 535) with videos related to

Pageof 54
Sort By:
Nature Communications|February 3, 2024
Gestational diabetes augments group B Streptococcus infection by disrupting maternal immunity and the vaginal microbiotaVicki Mercado-Evans, Marlyd E Mejia, Jacob J Zulk, et al.
Annals of Hematology|September 14, 2000
Transplant activities in Germany in 1998--a survey facilitated by the National Registry for Hemopoietic Stem Cell TransplantationH D Ottinger, C Müller, N Schmitz, et al.
British Journal of Haematology|February 23, 2018
High-dose melphalan-based sequential conditioning chemotherapy followed by allogeneic haematopoietic stem cell transplantation in adult patients with relapsed or refractory acute myeloid leukaemiaNina K Steckel, Christoph Groth, Jan-Henrik Mikesch, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 21, 2010
Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolatesElisabetta Bianchi, Joseph G Joyce, Michael D Miller, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2012
Prognostic factors affecting outcome after allogeneic transplantation for hematological malignancies from unrelated donors: results from a randomized trialJürgen Finke, Claudia Schmoor, Wolfgang A Bethge, et al.
Human Gene Therapy|February 20, 2025
Adeno-Associated Virus Gene Therapy Development: Early Planning and Regulatory Considerations to Advance the Platform Vector Gene Therapy ProgramRicha Madan Lomash, Jean Dehdashti, Oleg A Shchelochkov, et al.
Human Gene Therapy|June 19, 2026
Adeno-Associated Virus Gene Therapy Translation: Lessons from Early Regulatory MeetingsRodica Stan, Richa Madan Lomash, Oleg A Shchelochkov, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 30, 2019
miR-574-5p as RNA decoy for CUGBP1 stimulates human lung tumor growth by mPGES-1 inductionMeike J Saul, Isabell Baumann, Annalisa Bruno, et al.
Blood|January 15, 2020
External validation of models for KIR2DS1/KIR3DL1-informed selection of hematopoietic cell donors failsJohannes Schetelig, Henning Baldauf, Falk Heidenreich, et al.
Blood|April 7, 2011
Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-FreseniusGérard Socié, Claudia Schmoor, Wolfgang A Bethge, et al.
Pageof 54

Showing results (511-520 of 535) with videos related to

Sort By:
Pageof 54
Nature Communications|February 3, 2024
Gestational diabetes augments group B Streptococcus infection by disrupting maternal immunity and the vaginal microbiotaVicki Mercado-Evans, Marlyd E Mejia, Jacob J Zulk, et al.
Annals of Hematology|September 14, 2000
Transplant activities in Germany in 1998--a survey facilitated by the National Registry for Hemopoietic Stem Cell TransplantationH D Ottinger, C Müller, N Schmitz, et al.
British Journal of Haematology|February 23, 2018
High-dose melphalan-based sequential conditioning chemotherapy followed by allogeneic haematopoietic stem cell transplantation in adult patients with relapsed or refractory acute myeloid leukaemiaNina K Steckel, Christoph Groth, Jan-Henrik Mikesch, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 21, 2010
Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolatesElisabetta Bianchi, Joseph G Joyce, Michael D Miller, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2012
Prognostic factors affecting outcome after allogeneic transplantation for hematological malignancies from unrelated donors: results from a randomized trialJürgen Finke, Claudia Schmoor, Wolfgang A Bethge, et al.
Human Gene Therapy|February 20, 2025
Adeno-Associated Virus Gene Therapy Development: Early Planning and Regulatory Considerations to Advance the Platform Vector Gene Therapy ProgramRicha Madan Lomash, Jean Dehdashti, Oleg A Shchelochkov, et al.
Human Gene Therapy|June 19, 2026
Adeno-Associated Virus Gene Therapy Translation: Lessons from Early Regulatory MeetingsRodica Stan, Richa Madan Lomash, Oleg A Shchelochkov, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 30, 2019
miR-574-5p as RNA decoy for CUGBP1 stimulates human lung tumor growth by mPGES-1 inductionMeike J Saul, Isabell Baumann, Annalisa Bruno, et al.
Blood|January 15, 2020
External validation of models for KIR2DS1/KIR3DL1-informed selection of hematopoietic cell donors failsJohannes Schetelig, Henning Baldauf, Falk Heidenreich, et al.
Blood|April 7, 2011
Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-FreseniusGérard Socié, Claudia Schmoor, Wolfgang A Bethge, et al.
Pageof 54